CDC: Who will get COVID-19 vaccine first in U.S.?
CDC: Who will get COVID-19 vaccine first in U.S.?
CDC: Who will get COVID-19 vaccine first in U.S.? US Centers for Disease Control: It is recommended to give priority to supply to these 24 million people! Two COVID-19 vaccines may be distributed before Christmas in the United States.
On Tuesday local time, the US Centers for Disease Control and Prevention (CDC) Immunization Practice Advisory Committee held a meeting and gave recommendations on the order of vaccine allocation. The committee voted 13-1.
According to the latest statistics released by Johns Hopkins University in the United States, as of 14:27 Eastern Time on December 1, (3:27 December 2, Pacific Time), the cumulative number of confirmed cases of COVID-19 pneumonia in the United States reached 13,666470 The number of deaths reached 269,948. Compared with the data about 22 hours ago, there were 166,155 new confirmed cases in the United States and 2,313 new deaths.
According to overseas news on December 1, the former director of the U.S. Food and Drug Administration (FDA), Scott Gottlieb, said,
According to news from the US media CNBC on November 30, Gottlieb said that the large number of previous infections may have an impact on the spread of the COVID-19 virus in the United States in 2021, although the COVID-19 vaccine may be deployed throughout the United States in 2021. Gottlieb said on the “Squawk Box” program: “By the end of this year, we may have 30% of the American population infected.” There are approximately 330 million people in the United States. He added, “Look at states like North Dakota and South Dakota, the infection rate is about 30% to 35%, and the highest may reach 50%.”
Gottlieb emphasized that throughout the pandemic, the actual number of infections may be higher than the counted number of infections, because not all infected people have been tested and finally diagnosed. For example, at the beginning of November, the country’s daily cases were approximately 121,000; Gottlieb stated that the actual number of cases was much higher. He stated on November 6 that “we can only diagnose at most 1/5 The number of cases may be less than this, so at least 5 million cases are diagnosed every day, and the actual number of infections may be more.”
According to Xinhua News Agency, previously, US Secretary of Health and Human Services Alex Aza said in an interview with US media on November 30th.
Aza said that the US Food and Drug Administration’s external advisory group will review the emergency use authorization application for the COVID-19 vaccine submitted by Pfizer Pharmaceutical Co., Ltd. on December 10. If all goes well, the application may be approved in the next few days. In addition, Moderna’s COVID-19 vaccine may be approved a week later than Pfizer’s vaccine. .
Aza said the US federal government will deliver vaccines through its normal vaccine distribution system. The US Centers for Disease Control and Prevention will give recommendations on which groups should be given priority for vaccination.
The COVID-19 vaccine jointly developed by Pfizer and the German Biotech Company is an mRNA (messenger ribonucleic acid) vaccine. The two companies announced on November 18 that the results of phase 3 clinical trials showed that this vaccine is 95% effective in preventing new coronavirus infections. On November 20th, the two companies submitted an emergency use authorization application to the US Drug Administration.
The COVID-19 vaccine developed by Moderna in cooperation with the National Institute of Allergy and Infectious Diseases is also an mRNA vaccine. Moderna issued a statement on November 30 that the Phase 3 clinical trial results showed that the vaccine’s effectiveness in preventing new coronavirus infections reached 94.1%. The company plans to submit an emergency use authorization application to the US Drug Administration on the same day.
